-
admin
Posts
Supermicro Expands DCBBS with Precision-Engineered AI Rack Series to Accelerate Deployment and Time-to-Online
Industry-leading quality, factory pre-assembly, and modular design facilitate rapid integration of systems and liquid cooling components, shortening Time-to-Online (TTO) Ten Rack models available in 44OU,...
TraceLink’s No-Code Platform Enables Company-Specific Agentic Business Processes for the End-to-End Supply Network
Built on the Agentic Supply Chain Operating System, company-specific Agentic Business Processes enable organizations to orchestrate work across virtually any business process or business transaction...
Vericel Reports Second Quarter 2026 Financial Results, Raises Full-Year Financial Guidance and Announces Share Repurchase Program
Total Revenue Increased 22% to $77.5 Million, with MACI Revenue Growth of 23% Net Income of $2.2 Million and Free Cash Flow of $14.3 Million...
DT Midstream Reports Strong Second Quarter 2026 Results
DETROIT, July 30, 2026 (GLOBE NEWSWIRE) — DT Midstream, Inc. (NYSE: DTM) today announced second quarter 2026 reported net income of $112 million, or $1.09...
Allegro MicroSystems Reports First Quarter 2027 Results
First Quarter Sales Increased by 27% Year-over-Year to $259 Million MANCHESTER, N.H., July 30, 2026 (GLOBE NEWSWIRE) — Allegro MicroSystems, Inc. (“Allegro” or the “Company”)...
Loblaw Reports Second Quarter Revenue Growth of 4.1% and Adjusted Diluted Net Earnings Per Common Share Growth of 11.9%
BRAMPTON, Ontario, July 30, 2026 (GLOBE NEWSWIRE) — Loblaw Companies Limited (TSX: L) (“Loblaw” or the “Company”) announced today its unaudited financial results for the...
Casino Group: H1 2026 Financial data estimates
H1 2026 FINANCIAL DATA ESTIMATES (not yet approved and not subject to a limited review) This press release is intended to provide the market with...
Cellectar Biosciences to Report Second Quarter Financial Results and Host a Conference Call on Thursday, August 13, 2026
FLORHAM PARK, N.J., July 30, 2026 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development...
Aligos Therapeutics to Announce 2nd Quarter 2026 Financial Results on August 6, 2026
SOUTH SAN FRANCISCO, Calif., July 30, 2026 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biotechnology company focused on improving patient outcomes...
CytomX Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026
SOUTH SAN FRANCISCO, Calif., July 30, 2026 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics,...
